Skin and soft tissue infections in immunocompetent patients

American Family Physician

Volumn 81, Issue 7, 2010, Pages 893-899

  Breen, James Owen ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; LINEZOLID; PSEUDOMONIC ACID; RETAPAMULIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABSCESS; ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CELLULITIS; CLINICAL FEATURE; COMMUNICABLE DISEASE; DRUG COST; ERYSIPELAS; FEVER; FOLLICULITIS; FURUNCULOSIS; GASTROINTESTINAL SYMPTOM; HAND WASHING; HUMAN; HYPOTENSION; IMMUNOCOMPETENCE; IMPETIGO; LOADING DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYOPATHY; RASH; SKIN INFECTION; SOFT TISSUE INFECTION; STEVENS JOHNSON SYNDROME; SURGICAL DRAINAGE; SYMPTOM; TACHYCARDIA; WOUND IRRIGATION; REVIEW; STAPHYLOCOCCAL SKIN INFECTION; WOUND DRAINAGE;

ANTI-BACTERIAL AGENTS; DRAINAGE; HUMANS; IMMUNOCOMPETENCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 77952315246     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hersh AL, Chambers HF, Maselli JH, et al. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008,168(14):1585-1591.
2. Nichols RL, Florman S. Clinical presentations of soft-tissue infections and surgical site infections. Clin Infect Dis. 2001;33(suppl 2):S84-S93. (Pubitemid 32762926)
3. Merlino JI, Malangoni MA. Complicated skin and soft-tissue infections: diagnostic approach and empiric treatment options. Cleve Clin J Med. 2007,74(suppl 4):S21-S28.
4. Duong M, Markwell S, Peter J, et al. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient [published ahead of print May 5, 2009]. Ann Emerg Med. http://www.annemergmed.com/article/S0196-0644%2809%2900270-4/abstract (subscription required). Accessed March 5, 2010.
5. Stevens DL, Eron LL. Cellulitis and soft-tissue infections. Ann Intern Med. 2009;150(1):ITC11.
6. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36(2):131-139. (Pubitemid 36143409)
7. Stevens DL, Bisno AL, Chambers HF, et al., for the Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections [published corrections appear in Clin Infect Dis. 2006;42(8):1219 and Clin Infect Dis. 2005;41(12):1830]. Clin Infect Dis. 2005;41(10):1373-1406.
8. Lipsky BA, Itani K, Norden C, for the Linezolid Diabetic Foot Infections Study Group. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/ amoxicillin-clavulanate. Clin Infect Dis. 2004;38(1):17-24.
9. Wieman TJ. Principles of management: the diabetic foot. Am J Surg. 2005,190(2):295-299. (Pubitemid 40967943)
10. Moran GJ, Krishnadasan A, Gorwitz RJ, et al., for the EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674.
11. Skiest DJ, Brown K, Cooper TW, et al. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect. 2007;54(5):427-434. (Pubitemid 46567511)
12. Centers for Disease Control and Prevention. Community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). http://www.cdc.gov/ ncidod/dhqp/ar-mrsa-ca.html. Accessed January 19, 2010.
13. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus [published correction appears in N Engl J Med. 2007;357(13):1357]. N Engl J Med. 2007;357(4):380-390.
14. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S. aureus infection: a prospective investigation. Clin Infect Dis. 2007;44(4):471-482. (Pubitemid 46233247)
15. Sawyer RG. Detection and initial management of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Surg Infect (Larchmt). 2008;9(suppl 1):S11-S15.
16. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705-710.
17. Perl B, Gottehrer NP, Raveh D, et al. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin InfectDis. 1999;29(6):1483-1488. (Pubitemid 30022745)
18. Payne CJ, Walker TW, Karcher AM, et al. Are routine microbiological investigations indicated in the management of non-perianal cutaneous abscesses? Surgeon. 2008;6(4):204-206.
19. Wilson ML, Winn W. Laboratory diagnosis of bone, joint, soft-tissue, and skin infections. Clin Infect Dis. 2008;46(3):453-457. (Pubitemid 351263532)
20. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23(2):123-127. (Pubitemid 38222783)
21. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007;5100:4044-4048. (Pubitemid 350057804)
22. Bansal BC, Wiebe RA, Perkins SD, et al. Tap water for irrigation of lacerations. Am J Emerg Med. 2002;20(5):469-472.
23. Valente JH, Forti RJ, Freundlich LF, et al. Wound irrigation in children: saline solution or tap water? Ann Emerg Med. 2003;41(5):609-616.
24. Madaras-Kelly KJ, Remington RE, Oliphant CM, et al. Efficacy of oral beta-lactam versus non-beta-lactam treatment of uncomplicated cellulitis. Am J Med. 2008;121(5):419-425. (Pubitemid 351626004)
25. Koning S, Verhagen AP, van Suijlekom-Smit LW, et al. Interventions for impetigo. Cochrane Database Syst Rev 2004;(2):CD003261.
26. Hepburn MJ, Dooley DP, Skidmore PJ, et al., Hasewinkle WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med. 2004; 164(15):1669-1674.
27. Ruhe JJ, Smith N, Bradsher RW, et al. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis. 2007; 44(6)777-784. (Pubitemid 46365300)
28. Hyun DY, Mason EO, Forbes A, et al. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J. 2009;28(1):57-59.
29. Johns Hopkins University. Point-of-Care Information Technology Center. ABX guide. http://www.hopkins-abxguide.org (subscription required). Accessed February 19, 2010.
30. Weigelt J, Itani K, Stevens D, et al., for the Linezolid CSSTI Study Group. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2005;49(6):2260-2266.
31. Peterson LR. A review of tigecycline - the first glycylcycline. Int J Antimicrob Agents. 2008;32(suppl 4):S215-S222.
32. Raghavan M, Linden PK. Newer treatment options for skin and soft tissue infections. Drugs. 2004;64(15):1621-1642. (Pubitemid 39128001)
33. Seaton RA. Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother. 2008;62(suppl 3): iii15-iii23.
34. Davis SL, McKinnon PS, Hall LM, et al. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes. Pharmacotherapy. 2007;27(12):1611-1618. (Pubitemid 350234309)
35. Koning S, van der Wouden JC, Chosidow O, et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol. 2008; 158(5):1077-1082. (Pubitemid 351521449)
36. Ellis MW, Griffith ME, Dooley DP, et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin- resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother. 2007; 51(10):3591-3598. (Pubitemid 47519348)
37. Loeb M, Main C, Walker-Dilks C, et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev. 2003;(4):CD003340.